Protective effect and molecular mechanism of losartan on cerebral ischemia reperfusion injury in rats
Author:
Affiliation:

Department of Neurology, the Third Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning 121000, China)

Clc Number:

R743

  • Article
  • | |
  • Metrics
  • |
  • Reference [18]
  • | | | |
  • Comments
    Abstract:

    Aim To study the protective effect and molecular mechanism of losartan on cerebral ischemia reperfusion (IR) injury in rats. Methods 80 adult male SD rats were randomly divided into sham group, IR group, 2.5 mg/kg losartan group, 5.0 mg/kg losartan group and 5.0 mg/kg losartan+LY group. 2.5 mg/kg losartan group, 5.0 mg/kg losartan group, 5.0 mg/kg losartan+LY group were given losartan intragastrically for 14 days before modeling, and 5.0 mg/kg losartan+LY group was given phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002 intraventricular injection 30 minutes before modeling. The model of cerebral IR injury was established by thread embolism method. At 24 hours after reperfusion, the neurological deficit was evaluated, and the water content of brain tissue, cell apoptosis and expression of apoptosis related genes were measured. Results Compared with sham group, the brain water content, neurological deficit score, TUNEL positive rate and the levels of Bcl-2 associated X protein (Bax)/GAPDH, cytochrome C (CytC)/GAPDH, cleaved cysteinyl aspartate specific proteinase-3 (caspase-3)/pro-caspase-3 in brain tissue of rats in IR group were significantly increased, while the levels of B-cell lymphoma-2 (Bcl-2)/GAPDH, p-PI3K/PI3K, p-AKT/AKT in brain tissue were significantly decreased. Compared with IR group, the levels of the brain water content, neurological deficit score, TUNEL positive rate and the levels of Bax/GAPDH, CytC/GAPDH, cleaved-caspase-3/pro-caspase-3 in brain tissue of rats in 2.5 mg/kg losartan group, 5.0 mg/kg losartan group were significantly decreased, while the levels of Bcl-2/GAPDH, p-PI3K/PI3K, p-AKT/AKT in brain tissue were significantly increased. Compared with 5.0 mg/kg losartan group, the levels of the brain water content, neurological deficit score, TUNEL positive rate and the levels of Bax/GAPDH, CytC/GAPDH, cleaved-caspase-3/pro-caspase-3 in brain tissue of rats in 5.0 mg/kg losartan+LY group were significantly increased, while the levels of Bcl-2/GAPDH, p-PI3K/PI3K, p-AKT/AKT in brain tissue were significantly decreased. Conclusion Losartan can alleviate cerebral IR injury by up-regulating PI3K/AKT pathway in rats.

    Reference
    [1] Jahan R, Saver JL, Schwamm LH, et al.Association between time to treatment with endovascular reperfusion therapy and outcomes in patients with acute ischemic stroke treated in clinical practice.JAMA, 9,2(3):252-263.
    [2] Schultheiss M, Hrtig F, Spitzer MS, et al.Intravenous thrombolysis in acute central retinal artery occlusion--A prospective interventional case series.PLoS One, 8,3(5):e0198114.
    [3] Moussaddy A, Demchuk AM, Hill MD.Thrombolytic therapies for ischemic stroke:Triumphs and future challenges.Neuropharmacology, 8,4(Pt B):272-279.
    [4] Nuez RE, Javadov S, Escobales N.Angiotensin II-preconditioning is associated with increased PKCε/PKCδ ratio and prosurvival kinases in mitochondria.Clin Exp Pharmacol Physiol, 7,4(12):1201-1212.
    [5] Smeda JS, Daneshtalab N.Cerebrovascular recovery after stroke with individual and combined losartan and captopril treatment of SHRsp.Vascul Pharmacol, 7,6-98:40-52.
    [6] Chang Y, Huang W, Sun Q, et al.MicroRNA 634 alters nerve apoptosis via the PI3K/Akt pathway in cerebral infarction.Int J Mol Med, 8,2(4):2145-2154.
    [7] Lv MR, Li B, Wang MG, et al.Activation of the PI3K-Akt pathway promotes neuroprotection of the δ-opioid receptor agonist against cerebral ischemia-reperfusion injury in rat models.Biomed Pharmacother, 7,3:230-237.
    [8] Akioyamen L, Levine M, Sherifali D, et al.Cardiovascular and cerebrovascular outcomes of long-term angiotensin receptor blockade:meta-analyses of trials in essential hypertension.J Am Soc Hypertens, 6,0(1):55-69.
    [9] Sivasubramaniam S, Kumarasamy B.Pleiotropic effects of losartan in hypertensive patients with dyslipidemia.J Clin Diagn Res, 7,1(9):FC05-FC08.
    [10] Schiavoni VS, Silva JPD, Lizarte Neto FS, et al.Morphological and immunohistochemical analysis of proteins CASPASE 3 and XIAP in rats subjected to cerebral ischemia and chronic alcoholism.Acta Cir Bras, 8,3(8):652-663.
    [11] Enzmann G, Kargaran S, Engelhardt B.Ischemia-reperfusion injury in stroke:impact of the brain barriers and brain immune privilege on neutrophil function.Ther Adv Neurol Disord, 8,7(11):1756286418794184.
    [12] Pitt B, Bakris GL, Weir MR, et al.Long-term effects of patiromer for hyperkalaemia treatment in patients with mild heart failure and diabetic nephropathy on angiotensin-converting enzymes/angiotensin receptor blockers:results from AMETHYST-DN.ESC Heart Fail, 8,5(4):592-602.
    [13] Farsang C.Indications for and utilization of angiotensin receptor II blockers in patients at high cardiovascular risk.Vasc Health Risk Manag, 1,7:605-622.
    [14] Badr R, Hashemi M, Javadi G, et al.Assessment of global ischemic/reperfusion and tacrolimus administration on CA1 region of hippocampus:gene expression profiles of BAX and BCL2 genes.Bratisl Lek Listy, 6,7(6):358-362.
    [15] Xie YL, Zhang B, Jing L.MiR-125b blocks Bax/cytochrome C/caspase-3 apoptotic signaling pathway in rat models of cerebral ischemia-reperfusion injury by targeting p53.Neurol Res, 8,0(10):828-837.
    [16] Zhang ZL, Qin P, Liu Y, et al.Alleviation of ischaemia-reperfusion injury by endogenous estrogen involves maintaining Bcl-2 expression via the ERα signalling pathway.Brain Res, 7,5(1661):15-23.
    [17] Chang J, Yao X, Zou H, et al.BDNF/PI3K/Akt and Nogo-A/RhoA/ROCK signaling pathways contribute to neurorestorative effect of houshiheisan against cerebral ischemia injury in rats.J Ethnopharmacol, 6,4(194):1032-1042.
    [18] Zhu H, Zhang Y, Shi Z, et al.The neuroprotection of liraglutide against ischaemia-induced apoptosis through the activation of the PI3K/AKT and MAPK pathways.Sci Rep, 6,1(6):26859.
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

LEI Min, WU Lirong, LIU Ying. Protective effect and molecular mechanism of losartan on cerebral ischemia reperfusion injury in rats[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2020,28(3):213-218.

Copy
Share
Article Metrics
  • Abstract:737
  • PDF: 882
  • HTML: 0
  • Cited by: 0
History
  • Received:June 21,2019
  • Revised:September 18,2019
  • Online: January 20,2020
Article QR Code